FR2439014A1 - Microparticules contenant des agents therapeutiques ou medicinaux et leur application comme contraceptif - Google Patents
Microparticules contenant des agents therapeutiques ou medicinaux et leur application comme contraceptifInfo
- Publication number
- FR2439014A1 FR2439014A1 FR7925580A FR7925580A FR2439014A1 FR 2439014 A1 FR2439014 A1 FR 2439014A1 FR 7925580 A FR7925580 A FR 7925580A FR 7925580 A FR7925580 A FR 7925580A FR 2439014 A1 FR2439014 A1 FR 2439014A1
- Authority
- FR
- France
- Prior art keywords
- application
- contraceptive
- microparticles containing
- medicinal agents
- containing therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
MICROPARTICULES CONTENANT DES AGENTS THERAPEUTIQUES OU MEDICINAUX ET LEUR APPLICATION COMME CONTRACEPTIF. LES MICROPARTICULES RENFERMANT UN ANTIGENE OU UN ANTICORPS POUR L'IMMUNISATION ACTIVE OU PASSIVE DES ORGANES REPRODUCTEURS FEMELLES INTERNES SONT CARACTERISEES EN CE QU'ELLES CONTIENNENT UNE QUANTITE D'ANTIGENE OU D'ANTICORPS SUFFISANTE POUR PROVOQUER UNE REPONSE, INCORPOREE DANS UN MATERIAU DE MATRICE QUI EST BIOCOMPATIBLE ET BIODEGRADABLE, LESDITES MICROPARTICULES ETANT CAPABLES D'ETRE ACHEMINEES, APRES DEPOT DANS LE VAGIN, PAR LE MECANISME NATUREL DES ORGANES REPRODUCTEURS FEMELLES INTERNES A TRAVERS LE COL JUSQUE DANS L'UTERUS. APPLICATION EN TANT QU'AGENT CONTRACEPTIF.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95210978A | 1978-10-17 | 1978-10-17 | |
US96738078A | 1978-12-07 | 1978-12-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2439014A1 true FR2439014A1 (fr) | 1980-05-16 |
FR2439014B1 FR2439014B1 (fr) | 1983-12-09 |
Family
ID=27130325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7925580A Granted FR2439014A1 (fr) | 1978-10-17 | 1979-10-15 | Microparticules contenant des agents therapeutiques ou medicinaux et leur application comme contraceptif |
Country Status (13)
Country | Link |
---|---|
AU (1) | AU528186B2 (fr) |
CA (1) | CA1143289A (fr) |
CH (1) | CH645545A5 (fr) |
DE (1) | DE2940146A1 (fr) |
FR (1) | FR2439014A1 (fr) |
GB (1) | GB2034182B (fr) |
IE (1) | IE48851B1 (fr) |
IL (1) | IL58471A (fr) |
IT (1) | IT1124572B (fr) |
NL (1) | NL184723C (fr) |
NZ (1) | NZ191837A (fr) |
PH (1) | PH25638A (fr) |
SE (1) | SE7908520L (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0300102A1 (fr) * | 1987-07-21 | 1989-01-25 | The Stolle Research And Development Corporation | Méthode d'obtention de facteurs immunorégulateurs par immunisation de mammifères |
FR2620335A1 (fr) * | 1987-09-15 | 1989-03-17 | Berdal Pascal | Presentation pharmaceutique potentialisant l'effet cytotrophique des serums et/ou des anticorps antitissus animaux et/ou humains |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675189A (en) * | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
US5366734A (en) * | 1981-02-16 | 1994-11-22 | Zeneca Limited | Continuous release pharmaceutical compositions |
CH661206A5 (fr) * | 1983-09-23 | 1987-07-15 | Debiopharm Sa | Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes. |
US4816257A (en) * | 1985-09-20 | 1989-03-28 | Research & Education Institute, Harbor-Ucla Medical Center Inc. | Method for producing an in vivo environment suitable for human embryo transfer |
US5688519A (en) * | 1987-04-06 | 1997-11-18 | Leonard; Robert J. | Flash-flow fused medicinal implants |
US5000886A (en) * | 1987-05-26 | 1991-03-19 | American Cyanamid Company | Silicone-hardened pharmaceutical microcapsules and process of making the same |
US4897268A (en) * | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
US5084277A (en) * | 1988-08-30 | 1992-01-28 | Greco John C | Vaginal progesterone tablet |
US5922340A (en) | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
AU706541B2 (en) | 1995-06-09 | 1999-06-17 | Euro-Celtique S.A. | Formulations and methods for providing prolonged local anesthesia |
EP0954301A4 (fr) | 1996-06-24 | 2006-03-08 | Euro Celtique Sa | Methodes sures d'anesthesie locale |
US6046187A (en) | 1996-09-16 | 2000-04-04 | Children's Medical Center Corporation | Formulations and methods for providing prolonged local anesthesia |
US6248345B1 (en) | 1997-07-02 | 2001-06-19 | Euro-Celtique, S.A. | Prolonged anesthesia in joints and body spaces |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3887699A (en) * | 1969-03-24 | 1975-06-03 | Seymour Yolles | Biodegradable polymeric article for dispensing drugs |
US3594468A (en) * | 1969-04-01 | 1971-07-20 | Vincent R Saurino | Germicidal compositions |
US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US3875300A (en) * | 1972-12-18 | 1975-04-01 | Ortho Pharma Corp | Composition for sustained release of a medicament and method of using same |
AU513400B2 (en) * | 1976-03-04 | 1980-11-27 | Commonwealth Serum Laboratories Commission | Biodegradable, sustained release composition |
-
1979
- 1979-10-01 CA CA000336744A patent/CA1143289A/fr not_active Expired
- 1979-10-03 DE DE19792940146 patent/DE2940146A1/de active Granted
- 1979-10-05 IT IT26288/79A patent/IT1124572B/it active
- 1979-10-08 NL NLAANVRAGE7907432,A patent/NL184723C/xx not_active IP Right Cessation
- 1979-10-08 PH PH23143A patent/PH25638A/en unknown
- 1979-10-10 CH CH910579A patent/CH645545A5/de not_active IP Right Cessation
- 1979-10-11 AU AU51696/79A patent/AU528186B2/en not_active Ceased
- 1979-10-12 NZ NZ191837A patent/NZ191837A/en unknown
- 1979-10-15 SE SE7908520A patent/SE7908520L/ unknown
- 1979-10-15 GB GB7935719A patent/GB2034182B/en not_active Expired
- 1979-10-15 FR FR7925580A patent/FR2439014A1/fr active Granted
- 1979-10-16 IL IL58471A patent/IL58471A/xx not_active IP Right Cessation
- 1979-10-16 IE IE1966/79A patent/IE48851B1/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0300102A1 (fr) * | 1987-07-21 | 1989-01-25 | The Stolle Research And Development Corporation | Méthode d'obtention de facteurs immunorégulateurs par immunisation de mammifères |
FR2620335A1 (fr) * | 1987-09-15 | 1989-03-17 | Berdal Pascal | Presentation pharmaceutique potentialisant l'effet cytotrophique des serums et/ou des anticorps antitissus animaux et/ou humains |
WO1989002268A1 (fr) * | 1987-09-15 | 1989-03-23 | Pascal Berdal | Presentation pharmaceutique potentialisant l'effet cytotrophique des serums et/ou des anticorps antitissus animaux et/ou humains |
Also Published As
Publication number | Publication date |
---|---|
IT7926288A0 (it) | 1979-10-05 |
IE791966L (en) | 1980-04-17 |
SE7908520L (sv) | 1980-04-18 |
PH25638A (en) | 1991-08-31 |
CA1143289A (fr) | 1983-03-22 |
AU5169679A (en) | 1980-04-24 |
GB2034182A (en) | 1980-06-04 |
NZ191837A (en) | 1984-07-31 |
FR2439014B1 (fr) | 1983-12-09 |
GB2034182B (en) | 1983-07-27 |
DE2940146C2 (fr) | 1991-12-05 |
NL7907432A (nl) | 1980-04-21 |
IT1124572B (it) | 1986-05-07 |
DE2940146A1 (de) | 1980-04-30 |
CH645545A5 (de) | 1984-10-15 |
IL58471A0 (en) | 1980-01-31 |
IL58471A (en) | 1983-05-15 |
AU528186B2 (en) | 1983-04-21 |
NL184723B (nl) | 1989-05-16 |
NL184723C (nl) | 1989-10-16 |
IE48851B1 (en) | 1985-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2439014A1 (fr) | Microparticules contenant des agents therapeutiques ou medicinaux et leur application comme contraceptif | |
Pudney et al. | Immunobiology of the human penile urethra. | |
KR890011608A (ko) | 항원 항체 콘주게이트 | |
Yang et al. | Immune response after vaginal application of antigens in the rhesus monkey | |
Wira et al. | Effect of uterine immunization and oestradiol on specific IgA and IgG antibodies in uterine, vaginal and salivary secretions. | |
Martinez et al. | Potential contraceptive use of epididymal proteins: evidence for the participation of specific antibodies against rat epididymal protein DE in male and female fertility inhibition | |
Naz et al. | Development of antisperm contraceptive vaccine for humans: why and how? | |
Wild | Role of the cell surface in selection during transport of proteins from mother to foetus and newly born | |
US6045786A (en) | Topical application of antibodies for prophylaxis against sexually transmitted diseases and pregnancy | |
Cline et al. | Immunoglobulin receptors on a mouse mast cell tumor | |
Schwimmer et al. | Sperm-agglutinating antibodies and decreased fertility in prostitutes | |
Saltzman et al. | Long‐term vaginal antibody delivery: Delivery systems and biodistribution | |
Sell | Immunopathology. | |
Segal et al. | Contraceptive Technology Current and Prospective Methods | |
BARRON et al. | Chlamydial salpingitis in female guinea pigs receiving oral contraceptives | |
Naz | The fertilization antigen (FA-1): applications in immunocontraception and infertility in humans | |
CASSLÉN et al. | Cyclic variation of plasminogen activation in human uterine fluid and the influence of an intrauterine device | |
Brundin | An occlusive mechanism in the fallopian tube of the rabbit | |
Liu et al. | Cytotoxic effect of nephrotoxic serum on rat tissue culture. | |
Haneberg et al. | Distribution of monoclonal antibodies in intestinal and urogenital secretions of mice bearing hybridoma ‘backpack’tumours | |
Hanna et al. | Fasciola hepatica: development of monoclonal antibodies against somatic antigens and their characterization by ultrastructural localization of antibody binding | |
Kabanov | Design of target‐specific polymer conjugates and complexes for biomedical application | |
Gras et al. | Effect of cyclophosphamide on specific IgM and IgG responses and recovery during the various stages of persistent immunization in the Brucella-rabbit model | |
Parkes | THE FIFTH OLIVER BIRD LECTURE BIOLOGICAL CONTROL OF CONCEPTION | |
Xu | Perspectives of application of monoclonal antibody drug conjugate to family planning |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |